Endologix LLC announced it has reached a milestone of 1,000 patients who have been treated with percutaneous transmural ...

Abstract: Percutaneous puncture is a pivotal technique in diagnosing and treating hepatic lesions; however, traditional manual puncture methods rely heavily on the expertise of medical practitioners.

To gain familiarity with the commonly encountered complications associated with percutaneous coronary intervention (PCI). To develop strategies to treat and overcome complications encountered in the ...

The use of an AI-powered risk assessment tool cut the average length of stay for patients undergoing cardiac catheterization ...

Vadodara: A 36-year-old man with a rare condition—a crossed, non-fused, ectopic kidney—successfully underwent percutaneous ...

We should allow the underlying illness to take its course and not deprive a patient of a natural need that will cause him to ...

Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Objectives: Complications of intracranial hemorrhage (ICH) after percutaneous coronary intervention ...

Limited data exist on noncardiac surgery patients with prior percutaneous coronary intervention (PCI) in the contemporary era. The objective was to examine rate, characteristics, and outcomes of ...

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced that 1,000 patients ...

163.com Objectives The purpose of this study was to investigate whether fractional flow reserve (FFR) should be performed for patients with coronary artery disease (CAD) to guide the percutaneous ...

A comprehensive literature review. Med Stud 2023; 39: 376-80. 3. Shah AH, Osten M, Benson L, et al. Long-term outcomes of percutaneous closure of coronary artery fistulae in the adult: a single-center ...

A research team led by Prof. Liu Xuanyong from the Shanghai Institute of Ceramics of the Chinese Academy of Sciences has ...